Startups
Edit
Accession Therapeutics Limited
https://www.accessiontherapeutics.com/Last activity: 12.08.2024
Active
Accession Therapeutics Limited is developing novel immuno-oncology therapeutics – combining high specificity and potency to counter tumour diversity.
Overview
Employees
11-50
Total raised
$19.6M
Funding Rounds 1
| Date | Series | Amount | Investors |
| Sign up to see | Sign up to see | Sign up to see | Sign up to see |
Mentions in press and media 3
| Date | Title | Description |
| Sign up to see | Sign up to see | Sign up to see |
| Jul 26, 2024 | Leading innovation: 10 promising European startups focusing on biopharmaceuticals | Biopharmaceuticals, often known as bio-pharma, represent a dynamic sector within the pharmaceutical industry that uses biological processes to develop drugs and therapies. Unlike traditional pharmaceuticals, which are typically synthesized ... |
| Accession Therapeutics | “Accession Therapeutics Limited is developing novel immuno-oncology therapeutics – combining high specificity and potency to counter tumour diversity.” |
Reviews 0
FAQ about Accession Therapeutics Limited
How much funding has Accession Therapeutics Limited raised?
Accession Therapeutics Limited has raised $19.6M in total across 1 funding round.
What has the press written about Accession Therapeutics Limited?
Parsers VC has collected 3 articles mentioning Accession Therapeutics Limited, among them “Leading innovation: 10 promising European startups focusing on biopharmaceuticals” (Jul 26, 2024) and “Accession Therapeutics”.
Is Accession Therapeutics Limited still active?
Yes, Accession Therapeutics Limited is active; its latest activity on Parsers VC dates from Aug 12, 2024.